• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性纤维化间质性肺炎中前列腺素E主要尿代谢物(PGE-MUM)水平升高。

Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia.

作者信息

Horikiri Tsugumi, Hara Hiromichi, Saito Nayuta, Araya Jun, Takasaka Naoki, Utsumi Hirofumi, Yanagisawa Haruhiko, Hashimoto Mitsuo, Yoshii Yutaka, Wakui Hiroshi, Minagawa Shunsuke, Ishikawa Takeo, Shimizu Kenichiro, Numata Takanori, Arihiro Seiji, Kaneko Yumi, Nakayama Katsutoshi, Matsuura Tomokazu, Matsuura Masaaki, Fujiwara Mutsunori, Okayasu Isao, Ito Satoru, Kuwano Kazuyoshi

机构信息

Division of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

Division of Respiratory Diseases, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan.

出版信息

Respir Med. 2017 Jan;122:43-50. doi: 10.1016/j.rmed.2016.11.017. Epub 2016 Nov 24.

DOI:10.1016/j.rmed.2016.11.017
PMID:27993290
Abstract

BACKGROUND

Dysregulation of the prostaglandin E2 (PGE2) signaling pathway has been implicated in interstitial pneumonia (IP) pathogenesis. Due to the unstable nature of PGE2, available detection methods may not precisely reflect PGE2 levels. We explored the clinical usefulness of measuring stable prostaglandin E-major urinary metabolite (PGE-MUM) with respect to pathogenesis and extent of chronic fibrosing IP (CFIP), including idiopathic pulmonary fibrosis (IPF), as PGE-MUM is reflective of systemic PGE2 production.

METHODS

PGE-MUM was measured by radioimmunoassay in controls (n = 124) and patients with lung diseases (bronchial asthma (BA): n = 78, chronic obstructive pulmonary disease (COPD): n = 33, CFIP: n = 44). Extent of lung fibrosis was assessed by fibrosing score (FS) of computed tomography (CT) (FS1-4). Immunohistochemical evaluation of COX-2 was performed to find PGE2 producing cells in IPF. Human bronchial epithelial cells (HBEC) and lung fibroblasts (LFB) were used in in vitro experiments.

RESULTS

Compared to control, PGE-MUM levels were significantly elevated in CFIP. PGE-MUM levels were positively correlated with FS, and inversely correlated with %DLCO in IP (FS 1-3). COX-2 was highly expressed in metaplastic epithelial cells in IPF, but lower expression of EP2 receptor was demonstrated in LFB derived from IPF. TGF-β induced COX-2 expression in HBEC.

CONCLUSIONS

PGE-MUM, elevated in CFIP, is a promising biomarker reflecting disease activity. Metaplastic epithelial cells can be a source of elevated PGE-MUM in IPF.

摘要

背景

前列腺素E2(PGE2)信号通路失调与间质性肺炎(IP)的发病机制有关。由于PGE2性质不稳定,现有的检测方法可能无法准确反映PGE2水平。我们探讨了测量稳定的前列腺素E - 主要尿代谢产物(PGE - MUM)对于慢性纤维化IP(CFIP)(包括特发性肺纤维化(IPF))发病机制和程度的临床实用性,因为PGE - MUM反映了全身PGE2的产生。

方法

通过放射免疫分析法测量对照组(n = 124)和肺部疾病患者(支气管哮喘(BA):n = 78,慢性阻塞性肺疾病(COPD):n = 33,CFIP:n = 44)的PGE - MUM。通过计算机断层扫描(CT)的纤维化评分(FS)(FS1 - 4)评估肺纤维化程度。进行COX - 2的免疫组织化学评估以在IPF中找到产生PGE2的细胞。体外实验使用人支气管上皮细胞(HBEC)和肺成纤维细胞(LFB)。

结果

与对照组相比,CFIP中PGE - MUM水平显著升高。PGE - MUM水平与FS呈正相关,与IP(FS 1 - 3)中的%DLCO呈负相关。COX - 2在IPF的化生上皮细胞中高表达,但在IPF来源的LFB中EP2受体表达较低。TGF - β诱导HBEC中COX - 2表达。

结论

CFIP中升高的PGE - MUM是反映疾病活动的有前景的生物标志物。化生上皮细胞可能是IPF中PGE - MUM升高的来源。

相似文献

1
Increased levels of prostaglandin E-major urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia.慢性纤维化间质性肺炎中前列腺素E主要尿代谢物(PGE-MUM)水平升高。
Respir Med. 2017 Jan;122:43-50. doi: 10.1016/j.rmed.2016.11.017. Epub 2016 Nov 24.
2
Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia.具有自身免疫特征的间质性肺炎在慢性纤维性间质性肺炎患者中的特征和预后意义。
Respir Med. 2018 Apr;137:167-175. doi: 10.1016/j.rmed.2018.02.024. Epub 2018 Mar 1.
3
Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.肺肌成纤维细胞的特征是环氧合酶-2及其主要代谢产物前列腺素E2表达下调。
PLoS One. 2013 Jun 3;8(6):e65445. doi: 10.1371/journal.pone.0065445. Print 2013.
4
Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.结缔组织病相关间质性肺疾病中的血清B细胞活化因子(BAFF)水平
BMC Pulm Med. 2015 Sep 30;15:110. doi: 10.1186/s12890-015-0105-0.
5
[The expressions and meanings of BMP-7 and TGF-β in idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia].[骨形态发生蛋白-7和转化生长因子-β在特发性肺纤维化和特发性非特异性间质性肺炎中的表达及意义]
Zhonghua Jie He He Hu Xi Za Zhi. 2014 Sep;37(9):664-70.
6
Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.WNT5A在特发性肺纤维化中的表达及其在人肺成纤维细胞中受TGF-β和WNT7B的调控
J Histochem Cytochem. 2016 Feb;64(2):99-111. doi: 10.1369/0022155415617988. Epub 2015 Nov 4.
7
Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者肺组织中 c-FLIP 的分隔表达。
Am J Respir Cell Mol Biol. 2010 Feb;42(2):140-8. doi: 10.1165/rcmb.2008-0419OC. Epub 2009 Apr 16.
8
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.无放射学蜂窝状改变的特发性肺纤维化的预测因素:对接受肺组织采样的间质性肺疾病患者的横断面分析
Respir Med. 2016 Sep;118:88-95. doi: 10.1016/j.rmed.2016.07.016. Epub 2016 Jul 28.
9
Comparative study of transforming growth factor-β signalling and regulatory molecules in human and canine idiopathic pulmonary fibrosis.人类和犬特发性肺纤维化中转化生长因子-β信号传导与调节分子的比较研究
J Comp Pathol. 2014 May;150(4):399-407. doi: 10.1016/j.jcpa.2013.12.001. Epub 2013 Dec 10.
10
COX-2 is widely expressed in metaplastic epithelium in pulmonary fibrous disorders.环氧化酶-2在肺纤维性疾病的化生上皮中广泛表达。
Am J Clin Pathol. 2006 Nov;126(5):717-24. doi: 10.1309/PFGX-CLNG-2N17-PJX9.

引用本文的文献

1
Optimal positioning of biomarkers according to ulcerative colitis activity.根据溃疡性结肠炎活动情况对生物标志物进行最佳定位。
Sci Rep. 2025 Jun 6;15(1):19916. doi: 10.1038/s41598-025-04908-2.
2
Evaluation of a Chemiluminescent Enzyme Immunoassay for the Detection of Prostaglandin E-Major Urinary Metabolite (PGE-MUM).评价一种用于检测前列腺素 E-主要尿代谢物(PGE-MUM)的化学发光酶免疫分析。
J Clin Lab Anal. 2024 Oct;38(19-20):e25102. doi: 10.1002/jcla.25102. Epub 2024 Sep 16.
3
Utility of a rapid assay for prostaglandin E-major urinary metabolite as a biomarker in pediatric ulcerative colitis.
快速检测前列腺素 E-主要尿代谢产物作为儿童溃疡性结肠炎生物标志物的效用。
Sci Rep. 2023 Jun 19;13(1):9898. doi: 10.1038/s41598-023-37145-6.
4
Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease.生物标志物在炎症性肠病中的定位和作用。
Digestion. 2023;104(1):30-41. doi: 10.1159/000527846. Epub 2022 Nov 18.
5
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD.吸入伊洛前列素的抗纤维化作用:ILD 的一种新兴选择。
Adv Ther. 2022 Sep;39(9):3881-3895. doi: 10.1007/s12325-022-02229-8. Epub 2022 Jul 3.
6
Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite.粪便免疫化学潜血试验或前列腺素 E-主要尿代谢物预测临床缓解期溃疡性结肠炎复发。
Clin Transl Gastroenterol. 2022 Jul 1;13(7):e00501. doi: 10.14309/ctg.0000000000000501. Epub 2022 May 26.
7
Prostaglandin E-major urinary metabolite diagnoses mucosal healing in patients with ulcerative colitis in remission phase.前列腺素 E-主要尿代谢物诊断溃疡性结肠炎缓解期患者的黏膜愈合。
J Gastroenterol Hepatol. 2022 May;37(5):847-854. doi: 10.1111/jgh.15782. Epub 2022 Feb 14.
8
Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease.生物标志物在炎症性肠病诊断和治疗中的作用
Life (Basel). 2021 Dec 10;11(12):1375. doi: 10.3390/life11121375.
9
Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis.比较前列腺素 E-主要尿代谢产物和 C 反应蛋白水平以反映溃疡性结肠炎患者内镜评分。
Sci Rep. 2021 Aug 10;11(1):16205. doi: 10.1038/s41598-021-95761-6.
10
Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge.出院后3个月患有肺部后遗症的2019冠状病毒病(COVID-19)康复患者的血浆代谢组学分析
Clin Infect Dis. 2021 Dec 16;73(12):2228-2239. doi: 10.1093/cid/ciab147.